Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior Therapy | 12 | 2020 | 126 | 3.570 |
Why?
|
| Counseling | 12 | 2020 | 174 | 3.220 |
Why?
|
| Mass Screening | 13 | 2020 | 672 | 2.280 |
Why?
|
| Primary Health Care | 13 | 2020 | 726 | 1.990 |
Why?
|
| Advisory Committees | 7 | 2022 | 112 | 1.760 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 622 | 1.340 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 532 | 1.250 |
Why?
|
| Depression | 7 | 2019 | 486 | 1.200 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2020 | 54 | 1.170 |
Why?
|
| Depression, Postpartum | 2 | 2019 | 22 | 1.070 |
Why?
|
| Sexual Behavior | 2 | 2020 | 128 | 1.040 |
Why?
|
| Humans | 60 | 2022 | 17314 | 0.970 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 197 | 0.920 |
Why?
|
| Health Behavior | 5 | 2020 | 346 | 0.910 |
Why?
|
| Weight Loss | 3 | 2018 | 294 | 0.850 |
Why?
|
| United States | 18 | 2022 | 3866 | 0.830 |
Why?
|
| Suicide | 3 | 2013 | 116 | 0.810 |
Why?
|
| Feces | 3 | 2020 | 85 | 0.810 |
Why?
|
| Minerals | 1 | 2022 | 8 | 0.770 |
Why?
|
| Prescription Drugs | 2 | 2020 | 30 | 0.760 |
Why?
|
| Anti-Obesity Agents | 3 | 2018 | 18 | 0.750 |
Why?
|
| Antidepressive Agents | 4 | 2019 | 142 | 0.740 |
Why?
|
| Vitamins | 1 | 2022 | 60 | 0.740 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 425 | 0.710 |
Why?
|
| Adult | 28 | 2022 | 7500 | 0.660 |
Why?
|
| Health Education | 1 | 2020 | 82 | 0.640 |
Why?
|
| Exercise | 3 | 2020 | 515 | 0.620 |
Why?
|
| Adolescent | 22 | 2020 | 3538 | 0.620 |
Why?
|
| Risk Reduction Behavior | 3 | 2020 | 104 | 0.620 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 356 | 0.610 |
Why?
|
| Health Risk Behaviors | 1 | 2018 | 5 | 0.600 |
Why?
|
| Obesity Management | 1 | 2018 | 4 | 0.590 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 163 | 0.590 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 48 | 0.570 |
Why?
|
| Preventive Health Services | 4 | 2021 | 147 | 0.550 |
Why?
|
| Female | 32 | 2020 | 12396 | 0.550 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 193 | 0.550 |
Why?
|
| Neoplasms | 1 | 2022 | 446 | 0.540 |
Why?
|
| Pediatric Obesity | 1 | 2017 | 88 | 0.490 |
Why?
|
| Asthma | 11 | 2007 | 400 | 0.480 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 529 | 0.460 |
Why?
|
| Male | 26 | 2020 | 9804 | 0.460 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 169 | 0.460 |
Why?
|
| Obesity | 3 | 2018 | 814 | 0.450 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2015 | 215 | 0.450 |
Why?
|
| Pregnancy | 7 | 2020 | 1463 | 0.390 |
Why?
|
| Psychotherapy | 4 | 2020 | 56 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 310 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 312 | 0.340 |
Why?
|
| Aspirin | 3 | 2016 | 63 | 0.340 |
Why?
|
| Primary Prevention | 2 | 2022 | 62 | 0.310 |
Why?
|
| Middle Aged | 18 | 2020 | 7836 | 0.290 |
Why?
|
| Stomach | 1 | 2008 | 4 | 0.290 |
Why?
|
| Laparoscopy | 1 | 2008 | 46 | 0.280 |
Why?
|
| Gastric Bypass | 1 | 2008 | 71 | 0.260 |
Why?
|
| Child | 8 | 2020 | 2403 | 0.260 |
Why?
|
| Aged | 12 | 2020 | 6084 | 0.260 |
Why?
|
| Risk Assessment | 6 | 2014 | 1076 | 0.260 |
Why?
|
| Young Adult | 3 | 2020 | 2465 | 0.260 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 119 | 0.250 |
Why?
|
| Incidence | 5 | 2020 | 1266 | 0.250 |
Why?
|
| Hypertension | 3 | 2020 | 469 | 0.240 |
Why?
|
| Overweight | 4 | 2017 | 266 | 0.230 |
Why?
|
| Surveys and Questionnaires | 8 | 2020 | 1282 | 0.220 |
Why?
|
| Age Factors | 3 | 2020 | 878 | 0.220 |
Why?
|
| Pre-Eclampsia | 2 | 2014 | 40 | 0.210 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1151 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2022 | 85 | 0.210 |
Why?
|
| Vitamin A | 1 | 2022 | 14 | 0.190 |
Why?
|
| beta Carotene | 1 | 2022 | 17 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2020 | 1226 | 0.190 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 298 | 0.190 |
Why?
|
| Marijuana Abuse | 2 | 2020 | 43 | 0.190 |
Why?
|
| Quality of Life | 4 | 2007 | 499 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 21 | 0.180 |
Why?
|
| Lactones | 3 | 2017 | 11 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 38 | 0.180 |
Why?
|
| Health Maintenance Organizations | 7 | 2005 | 407 | 0.180 |
Why?
|
| Risk Factors | 7 | 2019 | 3258 | 0.170 |
Why?
|
| Narration | 1 | 2020 | 8 | 0.170 |
Why?
|
| Depressive Disorder, Major | 3 | 2009 | 100 | 0.170 |
Why?
|
| Language | 1 | 2020 | 49 | 0.170 |
Why?
|
| Colonoscopy | 2 | 2020 | 257 | 0.170 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 114 | 0.170 |
Why?
|
| Adolescent Health Services | 2 | 2001 | 40 | 0.170 |
Why?
|
| Tobacco Use | 1 | 2020 | 14 | 0.170 |
Why?
|
| Substance Abuse Detection | 1 | 2020 | 18 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2021 | 149 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2020 | 56 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 18 | 0.160 |
Why?
|
| Immunochemistry | 1 | 2020 | 18 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 120 | 0.160 |
Why?
|
| Serotonin Uptake Inhibitors | 3 | 2009 | 46 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 202 | 0.160 |
Why?
|
| Postal Service | 1 | 2020 | 72 | 0.160 |
Why?
|
| Public Health | 1 | 2020 | 83 | 0.150 |
Why?
|
| Sertraline | 1 | 2019 | 2 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2017 | 937 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2020 | 640 | 0.150 |
Why?
|
| Medicare | 1 | 2020 | 192 | 0.150 |
Why?
|
| Occult Blood | 2 | 2016 | 155 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 268 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 189 | 0.150 |
Why?
|
| Prognosis | 1 | 2020 | 603 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2019 | 157 | 0.140 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 2 | 0.140 |
Why?
|
| Managed Care Programs | 5 | 2007 | 300 | 0.140 |
Why?
|
| Child, Preschool | 4 | 2017 | 1380 | 0.130 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 12 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1098 | 0.130 |
Why?
|
| Metformin | 1 | 2017 | 50 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2011 | 1160 | 0.130 |
Why?
|
| Internet | 3 | 2017 | 212 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 203 | 0.120 |
Why?
|
| Remission Induction | 1 | 2016 | 26 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 44 | 0.120 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 19 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 3 | 0.120 |
Why?
|
| Microsatellite Instability | 1 | 2015 | 16 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2015 | 11 | 0.120 |
Why?
|
| Adenoma | 1 | 2016 | 95 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 250 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 52 | 0.110 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 53 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2020 | 704 | 0.110 |
Why?
|
| Street Drugs | 1 | 2014 | 12 | 0.110 |
Why?
|
| Smoking Prevention | 1 | 2013 | 35 | 0.100 |
Why?
|
| Diet | 1 | 2014 | 355 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2013 | 96 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2005 | 185 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 664 | 0.090 |
Why?
|
| Child of Impaired Parents | 2 | 2002 | 27 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2006 | 277 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2013 | 154 | 0.090 |
Why?
|
| Dementia | 1 | 2013 | 121 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 1039 | 0.090 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2010 | 24 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2010 | 46 | 0.080 |
Why?
|
| Data Collection | 3 | 2017 | 238 | 0.080 |
Why?
|
| Oregon | 6 | 2006 | 170 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 20 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 105 | 0.080 |
Why?
|
| Sex Counseling | 1 | 2008 | 2 | 0.070 |
Why?
|
| Telephone | 2 | 2006 | 150 | 0.070 |
Why?
|
| Unsafe Sex | 1 | 2008 | 19 | 0.070 |
Why?
|
| Organ Size | 1 | 2008 | 16 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 25 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 23 | 0.070 |
Why?
|
| Self Care | 2 | 2005 | 144 | 0.070 |
Why?
|
| Sick Role | 1 | 2006 | 9 | 0.060 |
Why?
|
| Self Concept | 1 | 2006 | 39 | 0.060 |
Why?
|
| Health Status | 3 | 2006 | 293 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cesarean Section | 1 | 2005 | 33 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 67 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2004 | 304 | 0.060 |
Why?
|
| Social Support | 1 | 2006 | 207 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2004 | 38 | 0.050 |
Why?
|
| Health Services | 2 | 2004 | 110 | 0.050 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 121 | 0.050 |
Why?
|
| Health Equity | 1 | 2021 | 22 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2002 | 89 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2001 | 16 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 357 | 0.040 |
Why?
|
| Reinforcement, Social | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cognitive Therapy | 1 | 2001 | 1 | 0.040 |
Why?
|
| Community Mental Health Services | 1 | 2001 | 32 | 0.040 |
Why?
|
| Aftercare | 1 | 2001 | 47 | 0.040 |
Why?
|
| Naloxone | 1 | 2020 | 18 | 0.040 |
Why?
|
| Food Analysis | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.040 |
Why?
|
| Parents | 1 | 2002 | 297 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2005 | 104 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 342 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 381 | 0.040 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 1998 | 1 | 0.040 |
Why?
|
| Mediastinoscopy | 1 | 1998 | 5 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 437 | 0.030 |
Why?
|
| Bias | 1 | 2017 | 96 | 0.030 |
Why?
|
| Colorado | 2 | 2007 | 164 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 23 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 25 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 26 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 45 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 65 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 24 | 0.030 |
Why?
|
| Health Surveys | 2 | 2006 | 245 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 176 | 0.030 |
Why?
|
| White Coat Hypertension | 1 | 2015 | 3 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 15 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 21 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 30 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 275 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 11 | 0.030 |
Why?
|
| Sex Factors | 2 | 2006 | 603 | 0.030 |
Why?
|
| Memantine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 4 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 11 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 36 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2014 | 106 | 0.030 |
Why?
|
| Algorithms | 2 | 2005 | 223 | 0.030 |
Why?
|
| Bupropion | 1 | 2013 | 9 | 0.030 |
Why?
|
| Comorbidity | 2 | 2007 | 560 | 0.020 |
Why?
|
| Life Style | 1 | 2014 | 316 | 0.020 |
Why?
|
| Premature Birth | 1 | 2014 | 132 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 128 | 0.020 |
Why?
|
| Decision Making | 1 | 2013 | 171 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2011 | 22 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 226 | 0.020 |
Why?
|
| Psychotherapy, Group | 2 | 2001 | 20 | 0.020 |
Why?
|
| Calcium Compounds | 1 | 2010 | 3 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2010 | 15 | 0.020 |
Why?
|
| Washington | 2 | 2002 | 384 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 43 | 0.020 |
Why?
|
| Lipids | 1 | 2010 | 69 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 429 | 0.020 |
Why?
|
| Prevalence | 2 | 2004 | 840 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2010 | 72 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2010 | 5 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 67 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 54 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 73 | 0.020 |
Why?
|
| Appetite Depressants | 1 | 2010 | 16 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 163 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 59 | 0.020 |
Why?
|
| Psychometrics | 1 | 2007 | 119 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 82 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 93 | 0.020 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2006 | 13 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2007 | 121 | 0.020 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 2 | 0.020 |
Why?
|
| Respiratory System Agents | 1 | 2005 | 2 | 0.020 |
Why?
|
| Birth Order | 1 | 2005 | 4 | 0.020 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2005 | 3 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 13 | 0.020 |
Why?
|
| Medical Audit | 1 | 2005 | 32 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2006 | 205 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 2005 | 8 | 0.020 |
Why?
|
| Maternal Age | 1 | 2005 | 74 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2005 | 16 | 0.010 |
Why?
|
| Cues | 1 | 2005 | 9 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 165 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 306 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1280 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2004 | 70 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 180 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2005 | 207 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 367 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 239 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 146 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2002 | 34 | 0.010 |
Why?
|
| Personality Assessment | 1 | 2001 | 11 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 460 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 48 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2001 | 19 | 0.010 |
Why?
|
| Patient Selection | 1 | 2002 | 176 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 270 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 25 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 124 | 0.010 |
Why?
|
| Health Policy | 1 | 2001 | 109 | 0.010 |
Why?
|
| Child Health Services | 1 | 2001 | 105 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1999 | 81 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 336 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 2415 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1998 | 1 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1998 | 8 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 55 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 26 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2001 | 274 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 1925 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 804 | 0.010 |
Why?
|
Concepts
(274)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->